Background/Aims: This study aimed to investigate the role of microRNA (miR)-122a in regulating zonulin during the modulation of intestinal barrier. Methods: Zonulin proteins and their target gene expression were analyzed in miR-122a-overexpressing cell lines and in the target gene of epidermal growth factor receptor (EGFR). An mmu-miR-122a intestinal epithelial conditional transgenic (miR-122a-TG) mouse model was established to investigate EGFR and zonulin expression. MiR-122a was also detected in the clinical specimens of inflammatory bowel disease. Results: EGFR was identified as a target gene of miR-122a. The expression level of miR-122a was positively correlated with that of zonulin. The expression level of zonulin was significantly increased, whereas the expression level of EGFR was significantly decreased in the miR-122a-TG mice and in the corresponding primary epithelial culture (P < 0.05). These results were consistent with the data of the clinical specimens. Conclusions: miR-122a could be a positive factor of zonulin by targeting EGFR, which increased the intestinal epithelial permeability in vivo and in vitro.
3′-untranslated regions (3′-UTRs) [1] . MiRNAs can participate in the regulation of gene expression in various critical biological processes, such as development, differentiation, apoptosis, and proliferation [2] Changes in miRNA expression are also associated with many diseases, including cancers [3] [4] [5] , heart diseases [6] , nervous system disorders, and intestinal barrier dysfunction [1, 7, 8] .
The relationship between miRNAs and intestinal epithelial barrier dysfunction has been rarely investigated [1, [7] [8] [9] [10] [11] . McKenna et al. determined the complete miRNA expression profile of the mammalian intestinal mucosa and the contribution of miRNAs to intestinal homeostasis by using Dicer1 loxP/loxP : Villin-Cre mutant mice and found a decrease in the expression of all miRNAs [11] . Intestinal barrier function is impaired in Dicer1-deficient mice and thus causes intestinal inflammation with lymphocyte and neutrophil infiltration. Tumor necrosis factor alpha (TNF)-α can rapidly increase the expression of miR-122a in enterocytes, cultured cells, and intestinal tissues and consequently induce occludin mRNA degradation and increase intestinal permeability [11] . Zonulin is a protein found in tight junctions in the intestinal tract and secreted by the cholera pathogen Vibrio cholerae, which was initially discovered in 2000 as the target of zonula occludens toxin [12] . Zonulin is also an indicator of intestinal permeability [12, 13] .
The relationship between miR-122a and zonulin expression levels has also been explored. We hypothesized that miR-122a can help protect intestinal barrier functions by regulating zonulin. We aimed to investigate the molecular mechanisms of miR-122a in zonulin regulation by targeting the epidermal growth factor receptor (EGFR).
Materials and Methods

Cell culture
Caco-2 cells purchased from ATCC (Manassas, VA) were grown under standard cell culture conditions and grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 U/ml of penicillin, and 100 μg/ml of streptomycin at 37°C in a humidified atmosphere containing 5% CO 2 . The cells were passaged at pre-confluent densities using 0.05% trypin and 0.5 mm of ethylenediaminetetraacetic acid (Gibco, USA), as previously described. For different groups, 5 μg/mL of lipopolysaccharide (LPS) (24 h) with dimethyl sulfoxide (DMSO) (48 h) was added for the treatment group, whereas phosphate-buffered saline (PBS) (24 h) with DMSO (48 h) was added for the control group.
Transfection of miR-122a overexpression lentivirus
The hsa-miR-122a cDNA was amplified by RT-PCR with human genomic DNA using 5′-TGGAGTGTGACAATGGTGTTTGT-3′ and 3′-ACCTCACACTCTTACCACAAACA-5′. The 5ʹ-and 3ʹ-primers contained BamH I and Xho I sites, respectively, as indicated by underlines. The amplified cDNA was inserted into the BamH I and Xho I sites of a mammalian expression plasmid vector, PGIP2 (Promega), at a site downstream of the cytomegalo virus promoter. Recombinant plasmid DNA was purified with a Qiagen plasmid kit (Qiagen, Valencia, CA, USA) and used to transfect NCM460 cells. The insert orientation was confirmed by sequencing. After transfection was performed using Tfx-50 reagent (Promega), the cells were cultured in the presence of G418, and the G418-resistant colonies were collected 2 weeks later. Cell clones were expanded individually, and clones expressing high levels of hsa-miR-122a on their surface were selected by flow-cytometric analysis with SN2Ab. A clone (designated as H11-SN2) that expressed hsa-miR122a on the cell surface at a similar level to that of NCM460 cells was used in this study [14] .
Building and identifying miR-122a transgenic mice
MiR-122a intestinal transgenic mice (mir-122a-TG) were generated by Cyagen Biosciences Inc. (Guangzhou, China) using a villin promoter and background mice of C57BL/6, as described [15] . Mice were bred and kept at the Sun Yat-Sen University Laboratory Animal Center (Guangzhou, China). All of the mice were raised under specific pathogen-free conditions with filtered air, fed rodent chow ad libitum, and allowed free access to water. Genotyping of mice was performed by PCR using genomic DNA isolated from the tail by the tissue DNA isolation kit (Biomiga, China). Animal studies were approved by the Animal Care Committee of the Sun Yat-Sen University. Mice were sacrificed at 8 weeks for determination. The concentrations of serum zonulin 24 h postoperatively were measured by using an enzyme-linked immunosorbent assay (ELISA) kit, as previously described [12] .
Isolation of intestinal epithelium and primary colon cell culture
The proximal and distal cecum and colon were opened along their vertical axis, and their luminal contents were removed by washing the tissues in PBS. Each segment was placed in Hanks' buffered saline solution (HBSS) containing 25 mM of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid and 1% calf serum (Sigma) (three washes of 5 min each, 20 ml/wash). RNA was isolated (RNeasy kit, Qiagen) from the cell pellets (epithelial fraction) and the remaining tissue fragments (mesenchymal fraction) [16] . The primary cell culture of mir-122a-TG colon was performed as described [17] .
Patients
Colon tissues were obtained from the surgical specimens of patients with inflammatory bowel disease (IBD) admitted for the operation. Blood samples were collected and stored properly. Clinical research was approved by the ethical committee of the Sixth Affiliated Hospital of Sun Yat-Sen University and the Fifth Affiliated Hospital of Guangzhou Medical University. Informed consents were obtained from the patients.
Luciferase assay
The resulting fragments containing intact putative miR-122a recognition sequences from the 3′-UTR or with random mutations were cloned in the psi-CHECK2 vector (Promega), as previously described. Caco-2 cells were cotransfected using Transit-TKO (Invitrogen) with the reporter plasmids and either the wild type (WT) or mutant vector. Luciferase assays were performed 48 h post-transfection following the protocol of the manufacturer (Dual-luciferase reporter assay system, E1910; Promega). The luciferase activities were measured with a Dual-Luciferase Report System (Promega).
RNA isolation
Total RNA was extracted from cells or tissue samples using Trizol lysis buffer (Ambion, USA) according to the instructions of the manufacturer. The microRNA isolation of cell or tissue or serum samples was performed with miRNeasy Mini Kit (Qiagen, Germany) according to the instructions of the manufacturer.
Quantitative real-time PCR (qRT-PCR) analysis
First strand synthesis of cDNA was performed with the Reverse Transcription Kit (Invitrogen, USA). A qRT-PCR for mRNA was performed using SYBR Master Mix (Invitrogen, USA) according to the instructions of the manufacturer and using a 7,500 Real-Time PCR system. First strand synthesis of cDNA was also performed with TaqMan MicroRNA Reverse Transcription Kit (ABI, USA). A qRT-PCR for microRNA was performed using TaqMan microRNA Assay (ABI, USA).
The qRT-PCR primer sequences were as follows:
Western blot analysis For Western blotting, proteins were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and then transferred to polyvinylidene difluoride membranes (Millipore, Massachusetts) using a wet electroblotter (Bio-Rad) for 120 min at 100 V. The membrane was then incubated with the appropriate primary antibody at 4°C overnight, washed three times (10 min each time) with Tris-buffered saline (TBS) containing 0.1% Tween 20 (TBS-T buffer), and then incubated for 1 h with the appropriate horseradish peroxidase-conjugated secondary antibody in TBS-T buffer for 4 h at 4°C. The membrane was washed three times (60 min each time) with TBS-T buffer and developed by the enhanced chemiluminescence [12] . The antibodies used in our study were anti-occludin antibody (EPR8208, ab167161), anti-claudin 1 antibody (EPRR18871, ab211737), anti-EGFR antibody (EP38Y, ab52894), and anti-haptoglobin antibody (HG-36, ab13429).
Permeability assay
The measurement of transepithelial electrical resistance (TER) and dextran permeability was described previously [18] . The intestinal epithelial monolayers were divided into five different experimental groups in triplicate. The measurement of the intestinal permeability and colonic damage in mice was performed as previously described [18] . Final data were reported as either the fractional excretion (for sucralose) to determine the colonic permeability or a ratio of fractional excretion (for lactulose/mannitol) to quantify the small intestinal permeability. Fractional excretion was defined as the fraction of the gavage dose recovered in the urine, and the ratio of fractional excretion was defined as the ratio of the fraction of the gavaged dose of lactulose recovered in the urine over the fraction of the gavaged dose of mannitol recovered in the urine. Ussing chamber assay was also used to determine the intestinal permeability measurement in isolated mice colons. Tissue ion resistance (1/G, where G represents the conductance) was calculated from the potential difference and short-circuit current according to Ohm's law [18] .
Statistical analysis
Data were statistically analyzed in GraphPad Prism 5 (San Diego, CA) and expressed as mean ± SEM. Statistical analysis was performed with paired Student's t test. P < 0.05 was defined as significant.
Results
LPS elicited damaging effects on tight junction
After LPS treatment was administered, the expression levels of Claudin-1 and occludin were significantly decreased in Caco-2 cells (Fig. 1 A&B, P < 0.05) , whereas the expression levels of miR-122a and zonulin were increased ( Fig. 1 C&D, 
Prediction of EGFR as a miR-122a target
The target miR-122a binding site was predicted using three different computational programs, TargetScan (http://www.targetscan.org/) [19] , PicTar (http://pictar.bio.nyu. edu.), [20] and miRanda (http://www.microrna.org/) [21] . After the three lists were generated by the three computational programs, a fourth list was generated, which contained the genes predicted by all the three initial computational programs (Table 1) . By the analysis of bioinformatics of MetaCore TM platform, we selected EGFR as the candidate Table 1 . Bioinformatics analysis of the score of the target gene of miRNA-21
Fig. 2. EGFR could be a target gene of miR-122a. (A) Over-expression of miR-122a increased the expression level of zonulin, while indicated no change of EGFR determined by qRT-PCR (B). (C)
Over-expression of miR-122a increased both the expression level of zonulin and EGFR determined by western blot and semi-quantitative analysis. (D, E) Co-overexpression of miR-122a and EGFR showed similar effects on zonulin expression, compared with the single overexpression of EGFR, which covered the effects of miR-122a both at the expression level of mRNA and protein determined by qRT-PCR and western blot and semi-quantitative analysis, whereas just over-expression of miR-122a mutated form indicated no difference with the control. (F) Luciferase assay indicated the target of miR-122a might be the 3'-UTR of EGFR. * P < 0.05. ** vs *, P > 0.05. Three independent experiments were performed.
with the highest score (Table 1) , which was reported as a mechanism that might ameliorate intestinal inflammation in mice [22] . We constructed EGFR mRNA 3′UTR vectors (WT and mutant) and inserted them immediately downstream of the luciferase reporter gene to determine whether EGFR was regulated by miR-122a through the direct binding of its 3′-UTR. In the luciferase assays, the miR-122a precursor or control was co-transfected into the Caco-2 cells with different 3′-UTR luciferase vectors. The miR-122a significantly decreased the relative luciferase activity in the WT 3′UTR of EGFR (P < 0.05, Fig 2F) . By contrast, relative luciferase activity did not decrease significantly in the UTRs with mutant-binding sites.
qRT-PCR and Western blot analysis showed that miR-122a could downregulate the expression level of zonulin in Caco-2 cell line transfected with miR-122a precursor (Fig. 2 A&C, P < 0.05). However, the expression level of EGFR was decreased significantly only in the protein level by Western blot rather than the mRNA level detected by qRT-PCR (Fig. 2 B&C , P < 0.05). Co-transfection of miR-122a and EGFR to Caco-2 cells leading to a similar decrease in zonulin expression to single transfection of EGFR indicated that miR-122a might have EGFRdependent effects on zonulin expression (Fig. 2 D&E, P < 0.05) . However, the overexpression of miR-122a-mutated form had no significant difference from the control (Fig. 2D , P > 0.05).
MiR-122a expression level correlated with the expression level of zonulin
In vivo experiments were also performed in miR-122a-TG mice to determine the effects of miR-122a on intestinal barrier. The colon tissues were performed for qRT-PCR and Western blot. The expression level of zonulin was more significantly increased in miR122a-TG mice than in the WT group both detected by qRT-PCR and Western blot, consistent with the outcomes in Caco-2 cell line, as reported above (Fig. 3A&C) . On the contrary, the expression level of EGFR was decreased more significantly in miR-122a-TG mice than in the WT group only detected by Western blot (Fig. 3B&C) . Similar results were indicated by the primary cell culture of miR-122a-TG epithelium (MCE-TG, Fig. 3 D-F) .
MiR-122a enhanced the intestinal permeability and inflammation in vitro and in vivo
The body weight of miR-122a-TG mice was significantly less than that of the control at 8 and 12 weeks. (P < 0.05, Fig. 5A ) A high mortality of the miR-122a-TG mice was observed. The TER was significantly lower after transfection of miR-122a into Caco-2 cells, whereas the relative intensity was significantly higher (P < 0.05, Fig. 4A ). Ussing chamber assay and fractional excretion (for lactulose/mannitol) also showed a higher permeability of miR122a-TG mice compared with the control WT group. The qRT-PCR assays revealed that IL-6 and TNF-α expression at the mRNA levels of serum both significantly increased in the miR122a-TG mice relative to the WT group. (P < 0.05, Fig. 4B, C) Clinical samples were also used to investigate the clinical feature of miR-122a. Fresh colon tissues of IBD and paired adjacent normal colon tissues were collected to determine tissue mR-122a expression level by qRT-PCR. The levels of miR-122a of the colon tissues of IBD were significantly higher than those of paired adjacent normal colon tissues. (P < 0.05, Fig. 5D ) The zonulin expression at the mRNA levels increased in the colon tissues of IBD relative to that of paired adjacent normal colon tissues. (P < 0.05, Fig. 5E ) The IL-6 and TNF-α levels in serum detected by ELISA kit (RayBiotech, USA) were increased in IBD patients than in healthy volunteers. (P < 0.05, Fig. 5F , G)
Discussion
Intestinal barrier mainly consists of complete intestinal epithelial cells [23] , with tight junction between the adjacent cells [24, 25] . Human intestine faces with the highest bacterial load, approximately more than 500 different types of microorganisms [26] . Therefore, we aim to investigate the relationship between microRNA and intestinal barrier function.
TNF-α could increase the expression of miR-122a in enterocytes, cultured cells, and intestinal tissue and thus induce degradation of occludin mRNA and increase the intestinal permeability [11] . By contrast, zonulin could be an indicator of intestinal barrier, which was initially discovered in 2000 as the target of zonula occludens toxin [12] . Our previous study indicated that the infection rate after peri-operative treatment of probiotics was lower than that of the control group [12] . Probiotics could decrease the serum zonulin, the duration of postoperative pyrexia, the duration of antibiotic therapy, and the rate of postoperative infectious complications [12] . Our present study aimed to investigate the molecular regulatory mechanism of miR-122a on the expression level of zonulin for treating intestinal barrier dysfunction. LPS was shown to be an injury factor on intestinal barrier [27] , and we first verified the effects of LPS on the expression level of zonulin and miR122a. The results indicated that the expression levels of miR-122a and zonulin were both increased after treating LPS. However, the expression level of EGFR was only decreased in the protein expression level, rather than the mRNA level determined by qRT-PCR, due to a posttranscript regulation of EGFR, such as regulated by miR-122a. MiR-122a-TG mice and the primary intestinal cell culture could further verify the regulatory effects of miR-122a on EGFR expression. MiR-122a might also be a regulator of intestinal barrier.
The luciferase assay verified EGFR as the target of miR-122a. The transfection of miR122a into the Caco-2 cells led to a decreased expression of EGFR only in the protein level determined by Western blot, which was inhibited at the posttranscript level, whereas the mRNA of EGFR was unaffected, as a regulatory mechanism of microRNA [1, 15, 28] . The cotranscription of EGFR with miR-122a could cover the effects of miR-122a on the increased expression level of zonulin possibly because the increased EGFR maintained the molecular regulatory inhibition on the expression of zonulin. Conversely, miR-122a could elicit its effects by inhibiting EGFR transcription.
The intestinal permeability was increased after the miR-122a overexpression and in the miR-122a-TG group, which was paralleled with the zonulin level, and this increase could be an indicator of intestinal permeability, as reported [12] . The inflammatory cytokines of IL-6 and TNF-α were also paralleled with the expression level of miR-122a. Therefore, we deduced that LPS could stimulate the expression of miR-122a and consequently inhibit the post-transcript expression of EGFR, increase expression, and promote intestinal permeability and intestinal inflammation (LPS-miR122a-EGFR-zonulin-intestinal permeability-inflammation). We supposed that LPS could induce intestinal barrier dysfunction via the miR-122a pathway.
In the molecular mechanism of miR-122a, miR-122 regulates the synthesis of the protein CAT-1; mRNA is targeted to P bodies, which can be relieved by the protein HuR, released from the nucleus under stress conditions [29] ; HuR interaction leads to the release of the mRNA from the P bodies [29] . Numerous other targets, such as CD320, AldoA, and BCKDK, have also been identified by microarray of changes in the liver of the mice treated with miR-122 inhibitors [30] [31] [32] . Other reports have shown that miR-122 can also regulate systemic iron homeostasis by Hjv and Hfe [33] , whereas inhibition of miR-122 in mice or primates does not result in any detectable liver toxicity [34] . The molecular mechanism of miR-122a, especially for zonulin, has not been reported. Our study investigated the molecular mechanism of miR-122a on the expression of zonulin through the pathway of EGFR, which is a cell surface receptor for members of the epidermal growth factor family of extracellular protein ligands [35] . Most studies on miR-122a have focused on hepatocellular carcinoma [36] , which could reduce the tumorigenic properties in HCC cell lines, and it functions as a tumor suppressor gene and increases the response to the chemotherapeutic drugs sorafenib [37] . Several miR-122 target genes have been identified, including ADAM10, IGF1R, CCNG1, and ADAM17 [37, 38] . Therefore, other signal transduction pathways also need further study. In our study, we mainly paid attention to the EGFR pathway, which could be regulated by miR-122a, thus leading to the alternation of zonulin. The molecular target, such as miR-122a, EGFR, and zonulin could be all used as potential therapeutic targets.
Our study might be limited by our insufficient investigations on the relationship between zonulin and tight-junction-associated proteins. Further tests may be essential for our future studies.
Conclusion
miR-122a could function as a positive factor of zonulin by targeting EGFR, which enhances intestinal epithelial permeability in vivo and in vitro.
